Special note: Zometa is only one medication. To read about ALL the Osteopenia medications, please go to Information about Osteopenia Medications
Zometa Osteoporosis information. Zometa is the marketing name of zoledronic acid, a drug prescribed to persons who have cancer caused bone loss. This drug was approved for use with those patients who have bone metastases from cancer. Zometa can prevent, delay and even treat complications – including pain and mobility problems. It has also been been studied as a once-a-year treatment for women who develop Osteoporosis after menopause. That is the reason it is included on this web site about Osteoporosis and Osteopenia.
Zometa belongs to the class of drugs called bisphosphonates. Actonel, Boniva, Clodronate, Fosamax, Minodronate ,Reclast (Aclasta) are some other bisphosphonate drugs used to treat Osteoporosis. (If you want to read about these other bisphosphonates just click on the link to each drug by name: Actonel ,Boniva, Clondronate , Fosamax ,Minodronate, Reclast/Aclasta.
All bisphosphonate drugs work by binding to the mineral surface of your bone and interfering with the work of osteoclasts, the bone cells that remove 'old' bone. When old bone is not removed, your bones show up as more dense on any bone density test.
Note: You have probably read or seen on news reports that some who have used bisphosophonates for several years have suffered sudden fractures. Some think that these fractures happen because their bones have too much 'old bone'.... bone the body would normally remove if the person was not taking a bisphosphonate drug.
Zometa is manufactured by Novartis, one of the world's largest drug companies. Concerning it use with cancer patients, the company says that Zometa is the only bisphosphonate "effective and approved in preventing SREs in multiple tumor types, including breast cancer, prostate cancer, lung cancer, multiple myeloma and other solid tumor types."
Zometa Osteoporosis information : Questions people frequently ask:
End of information: Zometa Osteoporosis information.
Source: Novartis, the company that makes this drug. I know that some of you like to read the scientific studies about things. One study was published in the New England Journal of Medicine. To read it just click Zometa Osteoporosis information (zolendronic acid) Once yearly treatment for Osteoporosis
Finally, the maker of this drug offers a page of useful information about the drug and its place in CANCER treatments. You can read that here: Zometa Osteoporosis information for those with cancer
Special update. In recent years there have been reports of serious side effects (and some lawsuits) from patients who used bisphonsphantes long term. Do discuss possible 'osteonecrosis' with your physician if you are considering this drug as an Osteoporosis treatment.
Click here for: More pharmaceutical medications for bone loss
NOTE: If you have used Zometa for Osteoporosis or Osteopenia and want to share your experience with others, please us the form below. (NOTE: I do not publish anonymous posts or posts with links.) Thank you for sharing.
Submissions from readers who have used this drug:
Readers like to read reviews from other readers. Can you do a review?
Click below to see contributions from other visitors to this page...